Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 1 EP application Thomas Claude Philippe Chantereau has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 07, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14747592

USE OF ANTI-MUC1 MAYTANSINOID IMMUNOCONJUGATE ANTIBODY FOR THE TREATMENT OF SOLID TUMORS

IPC classification:
A61P 35/00, A61K 47/48
Applicant:
Sanofi, S.A.
Agent:
Thomas Claude Philippe Chantereau, Sanofi
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature